Granules India Q2 Profit Surges 39% to Rs 182 Crore as Concor Declares Rs 1.90 Dividend Despite Earnings Dip
A bustling September-quarter earnings season brought contrasting scorecards for Dalal Street investors, as Hyderabad-based pharmaceutical manufacturer Granules India posted stellar double-digit profit growth while state-owned logistics heavyweight Container Corporation of India (Concor) rewarded shareholders with a dividend payout despite experiencing bottom-line strain.
Granules India: North American Demand Drives Operational Outperformance
Granules India reported a 39% year-on-year increase in consolidated net profit to Rs 181.8 crore for the quarter ended September 30, up from Rs 130.6 crore in the corresponding period of the previous fiscal year.
Consolidated revenue from operations advanced 20.3% year-on-year to Rs 1,560 crore, compared with Rs 1,297 crore in the year-ago period. Growth was largely underpinned by high-margin finished dosages and new product additions in regulated Western markets, which helped insulate the drugmaker against elevated input costs.
Key Financial and Segment Metrics:
- Operating Profitability: Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) grew 21% year-on-year to Rs 337.6 crore, while profit before tax climbed 38% to Rs 243.4 crore.
- Geographic Mix: North America continued to serve as the company's core growth engine, contributing 72% of total quarterly revenue, while Europe accounted for 16%.
- Business Breakdown: Finished dosage formulations formed the backbone of operational revenue at 73%, followed by active pharmaceutical ingredients (APIs) at 13%, pharmaceutical formulation intermediates (PFIs) at 10%, and the peptides CDMO vertical at 3%.
- Balance Sheet Health: Granules ended the quarter in a net cash position of Rs 828 crore, staging a sharp turnaround from a net debt posture of Rs 101.2 crore in the prior quarter.
Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India, observed that top-line performance crossed the Rs 1,500-crore threshold despite elevated raw material and shipping expenses stemming from West Asian geopolitical tensions.
Concor: Dividend Announced as Domestic Squeeze Weighs on Margins
State-run logistics provider Container Corporation of India Ltd. presented a mixed second-quarter scorecard marked by subdued top-line expansion and margin compression.
Concor’s consolidated net profit dropped 6.9% year-on-year to Rs 353 crore, down from Rs 379 crore in the corresponding quarter of the previous fiscal. Operating revenue registered modest growth, rising 1% year-on-year to Rs 2,379 crore from Rs 2,355 crore.
To reward shareholders, Concor’s board of directors declared a second interim dividend of Rs 1.90 per equity share for the financial year, fixing November 11 as the record date to determine eligible investors.
Operational and Segment Performance:
- EBITDA and Margins: Consolidated EBITDA declined 4.5% year-on-year to Rs 550 crore compared to Rs 576 crore in the year-ago period. As a result, operating margin contracted by 140 basis points to 23.1% from 24.5%.
- EXIM Stability: The flagship export-import (EXIM) division held steady, posting a 0.91% increase in revenue to Rs 1,591.78 crore and a 1.94% uptick in segment profit to Rs 432.12 crore.
- Domestic Drag: The domestic business encountered severe profitability headwinds. Although domestic revenue edged up 0.97% to Rs 781.43 crore, segment profit slumped by more than 77% to Rs 14.57 crore from Rs 64.42 crore a year earlier, acting as the primary anchor on consolidated earnings.
Investor Takeaway
For market participants tracking mid-cap pharma and public sector enterprises, the results offer distinct sector narratives. Granules India’s successful transition toward higher-value finished dosage forms and robust US market positioning continue to generate operating leverage and cash generation. Conversely, Concor’s consistent dividend policy cushions short-term volatility, but investors will closely monitor whether freight volumes and domestic rail logistics margins can stage a recovery over the second half of the fiscal year.